| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |